Xenon Pharmaceuticals Inc.

XENE · Healthcare

$60.00

Capitalizzazione: 5.81B USDRendimento da dividendo: —
AdvanceÈ un buon momento per comprare Xenon Pharmaceuticals Inc.? Chiedi a Copenvest AIOttieni un'analisi Advance con AI su timing, rischio e cosa fanno gli investitori tracciati.Chiedi a Copenvest AI

Caricamento grafico…

Notizie

Ultime notizie su questo titolo

Insider Monkey4 set 2026, 19:06

Xenon (XENE) Heads To Europe With Data That Could Reshape Epilepsy Care

GlobeNewswire3 set 2026, 20:01

Xenon to Present at Wells Fargo Healthcare Conference

Business Wire31 ago 2026, 14:49

BIOTECanada Announces 2026 Gold Leaf Award Winners, Recognizing Excellence Across Canada’s Biotechnology Ecosystem

GlobeNewswire28 ago 2026, 20:01

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Simply Wall St.28 ago 2026, 08:20

What Xenon Pharmaceuticals (XENE)'s New Azetukalner Phase 3 Epilepsy Data Means For Shareholders